Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11702646 Methods for modulating RNA splicing

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
PTC Therapeutics, Inc.
PTC Therapeutics, Inc.
0
Date Filed
November 27, 2017
0
Date of Patent
July 18, 2023
0
Patent Applicant
PTC Therapeutics, Inc.
PTC Therapeutics, Inc.
0
Patent Application Number
16463775
0
Patent Citations
‌
US Patent 8337941 Fluorescent substrates for monoamine transporters as optical false neurotransmitters
0
‌
US Patent 8633019 Methods for treating spinal muscular atrophy
0
‌
US Patent 8962842 2-pyridone antimicrobial compositions
0
‌
US Patent 9371336 Compounds for treating spinal muscular atrophy
0
‌
US Patent 9399649 Compounds for treating spinal muscular atrophy
0
‌
US Patent 9586955 Compounds for treating spinal muscular atrophy
0
‌
US Patent 9617268 Compounds for treating spinal muscular atrophy
0
‌
US Patent 9879007 Compounds for treating spinal muscular atrophy
0
‌
US Patent 9969754 Compounds for treating spinal muscular atrophy
0
‌
US Patent 10195202 Methods for modulating the amount of RNA transcripts
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11702646
0
Patent Primary Examiner
‌
Kimberly Chong
0

Find more entities like US Patent 11702646 Methods for modulating RNA splicing

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.